This thing is a lemon. I dont think they ever had a well thought out plan for commercialization. But AXE has been lucky. They have a very compliant retail shareholder cohort that has always put a positive spin on whatever happened or more accurately didn't happen. So even though, in the last 3 yrs, the SP has fallen over 90%, with only brief moments of recovery before continuing its relentless downward slide, we said nothing as the slide continued. It was only after the CEO bailed that we started to hear some rumblings but frankly Im beginning to think it was too late. I was hoping they had something in the pipeline that would give us reason to believe that some significant progress had been made towards commercializing at least the biochip but now I'm beginning to think that they havnt done much in that regard at all.
If you dont like what Im saying block me but Im not going to shut up. We watched this thing drop by 90% while the faithful, convinced they would be Billionaires within a few short months shouted down anyone who might have suggested that there was something seriously wrong with the AXE strategy and where did that get us? That's my opinion! DYOR
AXE Price at posting:
25.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)